Grand Launch of Saluseq Nimbo on NGS DISCOVERY DAY!
Exciting news from Bangkok! On November 7th, 2024, Saluseq Nimbo took the spotlight at NGS DISCOVERY DAY, a special event hosted by Gibthai Co., Ltd. This grand launch marks a major step forward for precision medicine and companion diagnostics in Thailand.
At this highly anticipated launch, Saluseq Nimbo took the spotlight of the event with its compact, high-integration design and fastest sequencing time of 3.4 hours, which will drive innovation in reproductive health, targeted NGS, companion diagnostics and forensics, etc.
During the event, Dr. Luyang Zhao, Salus BioMed’s Founder and CEO, delivered a presentation on “NGS Platforms: Shaping the Future of Clinical Diagnostics and Life Science Research.” He emphasized that NGS technology is rapidly advancing and adopted in both clinical and academic applications, serving as a foundational tool driving precision diagnostics and biomedical research, with significant growth potential in various industries. And the combination of genomic data and AI large models is expected to fuel innovation across fields like drug design and genomics, advancing breakthroughs in life sciences.
Our collaboration with Gibthai, announced in September, unites Salus BioMed’s advanced sequencing solutions with Gibthai’s extensive market expertise, creating a strong foundation for growth in Thailand’s sequencing market. Together, we’re advancing the innovation of life science research and diagnostics!
